{"nct_id":"NCT02836496","title":"Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)","status":"COMPLETED","status_verified_date":"2020-02","start_date":"2017-03-07","start_date_type":"ACTUAL","primary_completion_date":"2019-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}